Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse - PubMed (original) (raw)
Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapse
O M Garson et al. Cancer Genet Cytogenet. 1989.
Abstract
In order to investigate the cytogenetic patterns in relapsed acute myelogenous leukemia (AML), a clinical and cytogenetic follow-up of patients newly diagnosed for the Fourth International Workshop on Chromosomes in Leukemia (4IWCL) was evaluated at the 6IWCL. Information was received on 103 patients in relapse who were then classified into seven groups according to the diagnostic karyotype. These groups were: normal, t(8;21), t(15;17), +8, a single specific abnormality either numerical or structural other than those already listed, a single nonrandom or miscellaneous abnormality again either numerical or structural, and complex abnormalities. The patient's age, diagnostic FAB type, the number of relapses, the total survival time, and the karyotype in relapse were considered in each of these cytogenetic groups. The remission and survival rates were comparable in all groups except the +8 group, where patients relapsed earlier and had a shorter survival time. Multiple relapses occurred most frequently in the t(8;21) group, whereas none of the patients with t(15;17) relapsed more than once, although the total survival time was similar to the two groups. Thirty-nine percent of the patients relapsed with the same karyotype as at diagnosis. A more complex karyotype showing evolution was found in 53%, and 8% showed either a less-complicated karyotype or appeared to have reverted to normal. Numerical abnormalities in relapse frequently involved trisomy of chromosomes 8 and/or 21. There was a nonrandom development of 9q- with relapse in patients with t(8;21). A pericentric inversion of chromosome 4, and abnormality infrequently reported at diagnosis, was found in relapse in association with t(15;17), t(8;21), and +8 karyotypes. Changes considered to be typically secondary in nature involving 5q, 7q, and 12p were seen in only seven cases. Twenty-one patients who had an apparently normal karyotype at diagnosis remained normal in relapse, indicating that absence of clonal chromosome abnormality is a real observation in AML rather than a failure of detection.
Similar articles
- Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N, Kelemen K. Ertz-Archambault N, et al. Panminerva Med. 2017 Dec;59(4):308-319. doi: 10.23736/S0031-0808.17.03380-8. Panminerva Med. 2017. PMID: 29144072 Review. - Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia.
Estey E, Keating MJ, Pierce S, Stass S. Estey E, et al. Leukemia. 1995 Jun;9(6):972-6. Leukemia. 1995. PMID: 7596187 - The clinical significance of karyotype in acute myelogenous leukemia.
Arthur DC, Berger R, Golomb HM, Swansbury GJ, Reeves BR, Alimena G, Van Den Berghe H, Bloomfield CD, de la Chapelle A, Dewald GW, et al. Arthur DC, et al. Cancer Genet Cytogenet. 1989 Jul 15;40(2):203-16. doi: 10.1016/0165-4608(89)90025-3. Cancer Genet Cytogenet. 1989. PMID: 2766244 - [Cytogenetic abnormality and prognosis in childhood acute myeloblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
Katano N, Tsurusawa M, Hirota T, Horikoshi Y, Mimaya J, Iwai T, Kaneko Y, Tsuji Y, Fujimoto T. Katano N, et al. Rinsho Ketsueki. 1997 Aug;38(8):647-56. Rinsho Ketsueki. 1997. PMID: 9311270 Japanese. - [Cytogenetic findings in acute myelogenous leukemias (FAB M 1 to M 6)].
Prösch U, Stobbe H. Prösch U, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(4):481-94. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985. PMID: 2414178 Review. German.
Cited by
- HEMOPHAGOCYTOSIS BY BLASTS IN A CHILD WITH ACUTE MONOCYTIC LEUKEMIA AFTER CHEMOTHERAPY.
Farias MG, Freitas PAC, Spagnol F, Souza MV, Alegretti AP, Riegel M, Taniguchi ANR, Daudt LE. Farias MG, et al. Rev Paul Pediatr. 2021;39:e2019290. doi: 10.1590/1984-0462/2021/39/2019290. Epub 2020 Jul 3. Rev Paul Pediatr. 2021. PMID: 32638943 Free PMC article. - Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
Vosberg S, Greif PA. Vosberg S, et al. Genes Chromosomes Cancer. 2019 Dec;58(12):839-849. doi: 10.1002/gcc.22806. Epub 2019 Sep 3. Genes Chromosomes Cancer. 2019. PMID: 31478278 Free PMC article. Review. - The Association between PARP1 and LIG3 Expression Levels and Chromosomal Translocations in Acute Myeloid Leukemia Patients.
Pashaiefar H, Yaghmaie M, Tavakkoly-Bazzaz J, Hamidollah Ghaffari S, Alimoghaddam K, Izadi P, Ghavamzadeh A. Pashaiefar H, et al. Cell J. 2018 Jul;20(2):204-210. doi: 10.22074/cellj.2018.5210. Epub 2018 Mar 18. Cell J. 2018. PMID: 29633598 Free PMC article. - Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.
Hackl H, Astanina K, Wieser R. Hackl H, et al. J Hematol Oncol. 2017 Feb 20;10(1):51. doi: 10.1186/s13045-017-0416-0. J Hematol Oncol. 2017. PMID: 28219393 Free PMC article. Review. - Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease.
Kim H, Seol YM, Song MK, Choi YJ, Shin HJ, Park SH, Lee EY, Chung JS. Kim H, et al. Blood Res. 2016 Sep;51(3):175-180. doi: 10.5045/br.2016.51.3.175. Epub 2016 Sep 23. Blood Res. 2016. PMID: 27722128 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical